Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFκB: Implications for tolerance induction

Transplantation

Volumn 70, Issue 3, 2000, Pages 415-419

  Smiley, Stephen T ^a,b   Csizmadia, Vilmos ^a   Gao, Wei ^a   Turka, Laurence A ^c   Hancock, Wayne W ^a,d  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b TRUDEAU INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN GP 39; GLYCOPROTEIN GP 39 MONOCLONAL ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INHIBITOR PROTEIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; PROTEASOME INHIBITOR; RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT PLANNING;

EID: 0034663755     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008150-00005     Document Type: Article

References (30)

1. Improved graft survival aider renal transplantation in the United States, 1988 to 1996
2. Chronic allograft nephropathy: An update
3. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
4. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
5. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
6. CD40-gp39 interactions play a critical role during allograft rejection: Suppression of allograft rejection by blockade of the CD40-gp39 pathway
7. Chronic cardiac rejection in the LEW to F344 rat model blockade of CD28-B7 costimulation by CTLA41 g modulates T cell and macrophage activation and attenuates arteriosclerosis
8. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
9. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
10. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in non-human primates
11. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154
12. Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody
13. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
14. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand-reply
15. Inhibition of NF-kappa B activation in vitro and in vivo: Role of 26S proteasome
16. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses
17. Immunosuppressive therapy abrogates unresponsiveness to renal allograft induced by thymic recognition of donor antigens
18. CD40 Ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
19. Newer immunosuppressive drugs: A review
20. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: The missing link
21. The human gp39 promoter: Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation
22. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes
23. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction
24. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes
25. Diverse agents act at multiple levels to inhibit the rel/nf-kappa b signal transduction pathway
26. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: Signal-induced phosphorylation of IκB-α alone does not release active NF-κB
27. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli
28. Induction of allograft tolerance in the absence of fas-mediated apoptosis
29. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance